Safety and Immunogenicity of One Dose of Inactivated Trivalent Flu Vaccine Administered to Non-elderly Adult and Elderly Subjects

Clinical trial NCT01151059 · COMPLETED

Trial details

NCT number: NCT01151059
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Seasonal Influenza

Start date: 2010-06-01
Primary completion: 2010-06-01
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.